Dr. Ronald Howard Koenig is a Atlanta, Georgia based neurologist who is specialized in Neurology. Active license number of Dr. Ronald Howard Koenig is 14384 for Neurology in Georgia. His current practice location is 3350 Peachtree Rd Ne, Atlanta. Patients can reach him at 404-842-8071 or can fax him at 404-842-8115. Dr. Ronald Howard Koenig is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1336128800. Dr. Ronald Howard Koenig specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Ronald Howard Koenig speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1336128800
NPI Enumeration Date:
12 Jan, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Ronald Howard Koenig are as mentioned below.
License Number
Specialization
State
Status
14384
Neurology
Georgia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Ronald Howard Koenig 3510 Knollwood Dr Nw, Atlanta, Georgia
Zip:
30305-1022
Phone Number:
404-233-6266
Fax Number:
404-233-6267
Patients can reach Dr. Ronald Howard Koenig at 3350 Peachtree Rd Ne, Atlanta, Georgia or can call to book an appointment on 404-842-8071.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.